US Patent Issued to Immedica Pharma on June 17 for "Methods for production of human recombinant arginase 1 and uses thereof" (Texas Inventor)

ALEXANDRIA, Va., June 19 -- United States Patent no. 12,331,335, issued on June 17, was assigned to Immedica Pharma AB (Stockholm).

"Methods for production of human recombinant arginase 1 and uses thereof" was invented by Scott W. Rowlinson (Austin, Texas).

According to the abstract* released by the U.S. Patent & Trademark Office: "Described are methods for producing recombinant Arginase, such as PEGylated, cobalt-substituted recombinant human Arginase 1. Also described are pharmaceutical compositions comprising such recombinant Arginase, as well as methods of treatment and uses of such recombinant Arginase."

The patent was filed on June 20, 2023, under Application No. 18/338,255.

*For further information, including images, charts and t...